TrialProceedings of the National Academy of Sciences of the United States of America2019

Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.

Irena Kaplanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.